Literature DB >> 5032524

Urinary metabolites of 14 C-labeled thyroxine in man.

C S Pittman, M W Buck, J B Chambers.   

Abstract

Studies were carried out to determine the chemical structures of thyroxine metabolites after total deiodination. Normal subjects were given thyroxine labeled with (14)C on the nonphenolic ring and the alanine side chain, 8-11 mug/day for 10 days. By paper chromatography of fresh urine, six or more (14)C-labeled compounds were separated. The (14)C-labeled metabolites were concentrated by passing the urine through a nonionic polymeric adsorbent. Two major thyroxine metabolites were identified. The identification was made by three different methods: (a) chromatography, (b) synthesis of derivatives, and (c) recrystallization to constant specific activity. One (14)C-labeled metabolite was identified as thyroacetic acid or 4-phenoxy-(4'-hydroxy) phenyl-acetic acid. Another one was identified as thyronine. Of the total urinary (14)C radioactivity, 43.7% was recovered as thyroacetic acid and 19.8% was recovered as thyronine. Approximately one-fifth of each of these metabolites was present in the urine in bound form which released the free metabolites during acid hydrolysis. The average daily excretion of thyroacetic acid was 13.7% of the renal disposal rate of thyroxine, or approximately 7.5 mug/day. The average daily excretion of thyronine was 6.5% of the renal disposal rate of thyroxine or approximately 3.9 mug/day while the urinary iodide made up 64.7% of the renal disposal rate of thyroxine. Our findings provide the needed proof that the major metabolic pathways of thyroxine remove the iodine atoms by substituting hydrogen for iodine and leave the diphenyl ether nucleus intact.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5032524      PMCID: PMC292323          DOI: 10.1172/JCI106977

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

1.  [DEIODINATION IN VIVO OF H-3- AND I-125-3,5-THYROXIN].

Authors:  J NUNEZ; L RAPPAPORT; C JACQUEMIN; J ROCHE
Journal:  C R Seances Soc Biol Fil       Date:  1964

2.  The metabolism of ring-labeled L-thyroxine-C14 in vivo.

Authors:  C D WEST; E L SIMONS; M J GORTATOWSKI; L F KUMAGAI
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

3.  [Nature of the deiodination products of thyroid hormones labelled simultaneously with tritium and radioactive iodiine].

Authors:  J ROCHE; J NUNEZ; C JACQUEMIN
Journal:  Biochim Biophys Acta       Date:  1962-11-05

4.  Studies on the degradation of thyroid hormones in vitro with compounds labelled in either ring.

Authors:  L G PLASKETT
Journal:  Biochem J       Date:  1961-03       Impact factor: 3.857

5.  [Characterization of thyronine as the product of the deiodination of thyroxin by means of rat liver slices].

Authors:  S LISSITZKY; M T BENEVENT; M ROQUES; J ROCHE
Journal:  C R Seances Soc Biol Fil       Date:  1958

6.  Metabolites of radioactive L-thyroxine and L-triiodothyronine.

Authors:  E V FLOCK; J L BOLLMAN; J H GRINDLAY; B F McKENZIE
Journal:  Endocrinology       Date:  1957-10       Impact factor: 4.736

7.  The carbon structure of thyroxine metabolites in urine.

Authors:  C S Pittman; J B Chambers
Journal:  Endocrinology       Date:  1969-04       Impact factor: 4.736

8.  The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man.

Authors:  C S Pittman; J B Chambers; V H Read
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

9.  Metabolism of 131-I- and 14-C-labeled thyroxines.

Authors:  C S Pittman; C Shimizu
Journal:  Endocrinology       Date:  1966-12       Impact factor: 4.736

10.  Thyroxine degradation. II. Products of thyroxine degradation by rat liver microsomes.

Authors:  J WYNN; R GIBBS
Journal:  J Biol Chem       Date:  1962-11       Impact factor: 5.157

View more
  5 in total

1.  Random urine tests in the assessment of thyroid function.

Authors:  J F Finucane
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

Review 2.  Clinical pharmacokinetics of hypolipidaemic drugs.

Authors:  R Gugler
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

3.  3-Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo.

Authors:  Carolin S Hoefig; Simon F Jacobi; Amy Warner; Lisbeth Harder; Nancy Schanze; Björn Vennström; Jens Mittag
Journal:  Br J Pharmacol       Date:  2015-06-09       Impact factor: 8.739

4.  Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism.

Authors:  Claudia Musilli; Gaetano De Siena; Maria Elena Manni; Andrea Logli; Elisa Landucci; Riccardo Zucchi; Alessandro Saba; Riccardo Donzelli; Maria Beatrice Passani; Gustavo Provensi; Laura Raimondi
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

5.  A validated LC-MS/MS method for cellular thyroid hormone metabolism: Uptake and turnover of mono-iodinated thyroid hormone metabolites by PCCL3 thyrocytes.

Authors:  Keith H Richards; Nancy Schanze; Ray Monk; Eddy Rijntjes; Daniel Rathmann; Josef Köhrle
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.